<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04289415</url>
  </required_header>
  <id_info>
    <org_study_id>54204</org_study_id>
    <nct_id>NCT04289415</nct_id>
  </id_info>
  <brief_title>From Addiction to Employment.</brief_title>
  <acronym>IPS-SUD</acronym>
  <official_title>From Addiction to Employment. Effectiveness of Employment Support During Treatment for Substance Use Disorders. The Individual Placement and Support (IPS-SUD) Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South-Eastern Norway Regional Health Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian Directorate of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with substance use disorders have low employment rates and are to a large extent on
      the outside of the ordinary labor market. Individual Placement and Support (IPS) is an
      evidence based method developed to aid persons with severe mental disorders in obtaining
      ordinary work. IPS has been used clinically in the addiction field, but has been subject to
      little research. The trial &quot;From addiction to employment&quot; is a randomized controlled trial to
      investigate the effect of an IPS intervention on employment outcome among substance use
      disorder patients in specialized health care treatment in Oslo, Norway. The study is
      conducted at the Department for Substance Use Disorder Treatment at Oslo University Hospital.
      The trial begins to include patients March 1st 2020 and will include for two years, until
      February 28th 2022.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The target population in this project is patients in SUD treatment who wish to gain
      employment. The goal of the study is to determine the effectiveness of IPS in helping persons
      with SUD obtain ordinary employment. A pragmatic, two-arm, parallel, superiority, randomized
      controlled trial will be conducted. The project is financed through innovation funding from
      the South Eastern Norway Regional Health Authority, the Norwegian Directorate of Health and
      internal resources from OUS. Participants will be allocated randomly to either an employment
      specialist whom they will have individual contact with for the coming 13 months or shorter
      (intervention), or to a self-help and four-sessions work shop intervention (control
      comparison). The intervention fidelity will be assessed by external evaluators according to
      the Norwegian translation of the IPS Fidelity Scale. Patients will be recruited to the study
      over a period of two years, and followed for 18 months my data collection and up until 10
      years in national registries.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2032</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Pragmatic, two-arm, parallel, superiority, randomised controlled trial</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Any employment</measure>
    <time_frame>From inclusion in the trial to 18 month after inclusion in the trial</time_frame>
    <description>At least 1 day of competitive employment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total time worked</measure>
    <time_frame>From inclusion in the trial to 18 month after inclusion in the trial</time_frame>
    <description>Number of days/hours worked</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to employment</measure>
    <time_frame>From inclusion in the trial to 18 month after inclusion in the trial</time_frame>
    <description>Time from inclusion in the trial to first employment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of jobs</measure>
    <time_frame>From inclusion in the trial to 18 month after inclusion in the trial</time_frame>
    <description>Number of different jobs kept</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Job duration</measure>
    <time_frame>From inclusion in the trial to 18 month after inclusion in the trial</time_frame>
    <description>Duration of longest employment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Employment relevant activity</measure>
    <time_frame>From inclusion in the trial to 18 month after inclusion in the trial</time_frame>
    <description>Whether the participant is engaged in education, training or other job-preparing activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental distress</measure>
    <time_frame>From inclusion in the trial and at different time points up until 18 month after inclusion in the trial</time_frame>
    <description>Information obtained from the Hospital Anxiety and Depression Scale (minumum score is 0, maximum score is 42, higher score means worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Past month substance use</measure>
    <time_frame>From inclusion in the trial and at different time points up until 18 month after inclusion in the trial</time_frame>
    <description>Information obtained from the European Addiction Severity Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants' quality of life</measure>
    <time_frame>From inclusion in the trial and at different time points up until 18 month after inclusion in the trial</time_frame>
    <description>Information obtained from the EQ-5D-5L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants' work related quality of life</measure>
    <time_frame>From inclusion in the trial and at different time points up until 18 month after inclusion in the trial</time_frame>
    <description>Information obtained from the Work and Social Adjustment Scale (minimum score is 0, maximum score is 40, higher score means more impairment)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Current employment status and employment during the period</measure>
    <time_frame>From inclusion in the trial and up until 10 years after inclusion in the trial</time_frame>
    <description>Information obtained from the State Register of Employers and Employees</description>
  </other_outcome>
  <other_outcome>
    <measure>Health Economic Cost-Benefit Assessment</measure>
    <time_frame>From inclusion in the trial and up until 10 years after inclusion in the trial</time_frame>
    <description>The assessment will include contacts with the specialized health care system (information from the National Patient Registry), contacts with the community and municipal health care and substance use treatment system (information obtained from the Municipal Patient and User Registry), reception of welfare benefits (information obtained from the FD-trygd Database) and employment (information obtained from the State Register of Employers and Employees)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Substance Use Disorders</condition>
  <arm_group>
    <arm_group_label>Individual Placement and Support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention used in this study will be a time-limited version of IPS. The employment specialist offers up until nine months job-search support and four months in-work support, giving a total of 13 months job-related support. If a participant succeeds in obtaining work before nine months has passed the remaining job-search support months may be transferred to in-work support time.
In the follow-up time while seeking employment, the employment specialists will work with the participants to identify skills and aspirations, establish contact with potential employers and ensure economic advice and help with benefits planning. The in-work support involves individual and regular contact with the participant and the employer.
All participants who receive this intervention will do so in addition to their clinical treatment. The treatment provider and the employment specialist should cooperate and clarify roles together with the patient.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Selv help kit and work shop</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants in the control intervention will be offered a self-help tool kit and a following introduction course to help participants see what their opportunities are, and specific tips on how to get further help. The course will last three hours a session over four days, with the offer of an individual one hour follow up session with the course leader when the course is over. The goal of the control group intervention is to enable the participants to make use of the services offered at the ordinary labor and welfare service.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Individual Placement and Support</intervention_name>
    <description>Employment specialist will work together with the participants in accordance to the method IPS in order to help the participant obtain competitive employment</description>
    <arm_group_label>Individual Placement and Support</arm_group_label>
    <arm_group_label>Selv help kit and work shop</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  In treatment, unemployed, want to obtain ordinary, competitive employment

        Exclusion Criteria:

          -  coercive treatment that disables the patient to engage in the intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eline Rognli, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eline Rognli, PhD</last_name>
    <phone>+ 47 48052157</phone>
    <email>elboka@ous-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Espen Arnevik, PhD</last_name>
    <phone>+47 41209898</phone>
    <email>esarne@ous-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department for Substance Use Treatment, Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Beate SÃ¦trang</last_name>
    </contact>
    <contact_backup>
      <last_name>Espen Arnevik</last_name>
      <email>esarne@ous-hf.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 25, 2020</study_first_submitted>
  <study_first_submitted_qc>February 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Eline Borger Rognli</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

